Sequential Alterations in the Micro-localization of Catalase in Mouse Liver After Treatment with Hypolipidemic Drugs

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 1984 Nov 1

PMID 6521730

Citations 7

Authors

E Klucis

D Crane

C Masters

Affiliations

Soon will be listed here.

Abstract

A comparative study has been carried out on the micro-localization of catalase in mouse tissues subsequent to treatment with a representative range of hypolipidemic drugs. A commonality of effect was shown by clofibrate (ethyl-alpha-p-chlorophenoxyisobutyrate), Wy-14,643 (4-chloro-6-[2,3 xylidino)-2-pyrimidinylthio] acetic acid), RMI-15,414 (5-tetradecyloxy-2-furancarboxylic acid) and aspirin (acetyl salicylic acid), in that treatments with each of these drugs was associated with the release of peroxisomal catalase into the cytoplasmic compartment of liver and kidney. It was also noticeable that this increased cytosolic activity was characterized by the presence of an 'aged' form of the enzyme with different mobility and activity characteristics to that of the peroxisomal enzyme. Possible molecular bases for these effects and their relationship to peroxisomal biogenesis are discussed.

Citing Articles

Modification in oxidative stress, inflammation, and lipoprotein assembly in response to hepatocyte nuclear factor 4alpha knockdown in intestinal epithelial cells.

Marcil V, Seidman E, Sinnett D, Boudreau F, Gendron F, Beaulieu J J Biol Chem. 2010; 285(52):40448-60.

PMID: 20871093 PMC: 3003343. DOI: 10.1074/jbc.M110.155358.

IRAK-1 contributes to lipopolysaccharide-induced reactive oxygen species generation in macrophages by inducing NOX-1 transcription and Rac1 activation and suppressing the expression of antioxidative enzymes.

Maitra U, Singh N, Gan L, Ringwood L, Li L J Biol Chem. 2009; 284(51):35403-11.

PMID: 19850916 PMC: 2790969. DOI: 10.1074/jbc.M109.059501.

PPAR and liver injury in HIV-infected patients.

Lemoine M, Capeau J, Serfaty L PPAR Res. 2009; 2009:906167.

PMID: 19390649 PMC: 2669659. DOI: 10.1155/2009/906167.

On the compartmentalization of catalase, fatty acyl-CoA oxidase and urate oxidase in mammalian livers, and the influence of clofibrate treatment on this microlocalization.

Hemsley A, Pegg M, Crane D, Masters C Mol Cell Biochem. 1988; 83(2):187-94.

PMID: 3200253 DOI: 10.1007/BF00226146.

Changes to the integral membrane protein composition of mouse liver peroxisomes in response to the peroxisome proliferators clofibrate, Wy-14,643 and di(2-ethyl-hexyl)phthalate.

Crane D, Chen N, Masters C Mol Cell Biochem. 1988; 81(1):29-36.

PMID: 3173343 DOI: 10.1007/BF00225650.

References

Appelkvist E, BRUNK U, Dallner G . Isolation of peroxisomes from rat liver using sucrose and Percoll gradients. J Biochem Biophys Methods. 1981; 5(4):203-17. DOI: 10.1016/0165-022x(81)90045-2. View

Leighton F, Coloma L, Koenig C . Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver. J Cell Biol. 1975; 67(2PT.1):281-309. PMC: 2109608. DOI: 10.1083/jcb.67.2.281. View

Crane D, Holmes R, MASTERS C . Synthesis and incorporation of phospholipid by peroxisomes of mouse liver. Biochim Biophys Acta. 1982; 712(1):57-64. DOI: 10.1016/0005-2760(82)90084-4. View

Flatmark T, CHRISTIANSEN E, Kryvi H . Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate. Eur J Cell Biol. 1981; 24(1):62-9. View

Roels F . Cytochemical demonstration of extraperoxisomal catalase. I. Sheep liver. J Histochem Cytochem. 1976; 24(6):713-24. DOI: 10.1177/24.6.950458. View

MASTERS C . On the turnover and multiplicity of peroxisomal catalases. Ann N Y Acad Sci. 1982; 386:301-13. DOI: 10.1111/j.1749-6632.1982.tb21424.x. View

Platt D, Thorp J . Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate. Biochem Pharmacol. 1966; 15(7):915-25. DOI: 10.1016/0006-2952(66)90168-7. View

Svoboda D, AZARNOFF D . Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB). J Cell Biol. 1966; 30(2):442-50. PMC: 2107000. DOI: 10.1083/jcb.30.2.442. View

Riede U, ROHR H . [The reaction pattern of liver-peroxysomes (equal microbodies) during cell-injury (author's transl)]. Beitr Pathol. 1974; 151(2):111-33. View

10.

Reddy J, Warren J, Reddy M, Lalwani N . Hepatic and renal effects of peroxisome proliferators: biological implications. Ann N Y Acad Sci. 1982; 386:81-110. DOI: 10.1111/j.1749-6632.1982.tb21409.x. View

11.

Legg P, Wood R . New observations on microbodies. A cytochemical study on CPIB-treated rat liver. J Cell Biol. 1970; 45(1):118-29. PMC: 2107995. DOI: 10.1083/jcb.45.1.118. View

12.

Fujiki Y, Fowler S, Shio H, Hubbard A, Lazarow P . Polypeptide and phospholipid composition of the membrane of rat liver peroxisomes: comparison with endoplasmic reticulum and mitochondrial membranes. J Cell Biol. 1982; 93(1):103-10. PMC: 2112093. DOI: 10.1083/jcb.93.1.103. View

13.

BEERS Jr R, SIZER I . A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952; 195(1):133-40. View

14.

Hess R, Staubli W, RIESS W . Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature. 1965; 208(5013):856-8. DOI: 10.1038/208856a0. View

15.

Parthasarathy S, Kritchevsky D, Baumann W . Hypolipidemic drugs are inhibitors of phosphatidylcholine synthesis. Proc Natl Acad Sci U S A. 1982; 79(22):6890-3. PMC: 347239. DOI: 10.1073/pnas.79.22.6890. View

16.

KALCKAR H . Differential spectrophotometry of purine compounds by means of specific enzymes; determination of hydroxypurine compounds. J Biol Chem. 2010; 167(2):429-43. View

17.

Donaldson R, Tolbert N, Schnarrenberger C . A comparison of microbody membranes with microsomes and mitochondria from plant and animal tissue. Arch Biochem Biophys. 1972; 152(1):199-215. DOI: 10.1016/0003-9861(72)90208-1. View

18.

Holmes R, MASTERS C . Species specific features of the distribution and multiplicity of mammalian liver catalase. Arch Biochem Biophys. 1972; 148(1):217-23. DOI: 10.1016/0003-9861(72)90134-8. View

19.

Reddy J, Bunyaratvej S, Svoboda D . Microbodies in experimentally altered cells. IV. Acatalasemic (CSb) mice treated with CPIB. J Cell Biol. 1969; 42(2):587-96. PMC: 2107684. DOI: 10.1083/jcb.42.2.587. View

20.

Masters C, Holmes R . Peroxisomes: new aspects of cell physiology and biochemistry. Physiol Rev. 1977; 57(4):816-82. DOI: 10.1152/physrev.1977.57.4.816. View